共 149 条
[1]
Tam CS(2006)Fludarabine, Cyclophosphamide, and Rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin's lymphoma Cancer 106 2412-2420
[2]
Wolf M(2005)Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma J Clin Oncol 23 694-704
[3]
Prince HM(2008)Phase III trial of consolidation therapy with Yttrium-90-Ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma J Clin Oncol 26 5156-5164
[4]
Januszewicz EH(2009)Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: A review of the evidence The Oncologist 14 17-29
[5]
Westerman D(2003)Safety of Yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphoma J Clin Oncol 21 1263-1270
[6]
Lin IK(2006)Treatment with Yttrium-90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma Leuk Lymphoma 47 629-636
[7]
Carney D(2007)Long-term responses in patients with recurring or refractory B-cell non-Hodgkin's lymphoma treated with Yttrium-90 ibritumomab tiuxetan Cancer 109 1804-1810
[8]
Seymour JF(2005)Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I-131-tositumomab for untreated follicular lymphoma J Clin Oncol 23 5696-5704
[9]
Czuczman MS(2006)Phase II trial of CHOP chemotherapy followed by I-131-tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five years follow up of Southwest Oncology Group Protocol 59911 J Clin Oncol 24 4143-4129
[10]
Koryzna A(2007)Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma Cancer 110 121-128